-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Science and Technology Daily, Beijing, February 8 (Intern reporter Zhang Jiaxin) According to a paper published in the journal "Nature Medicine" on the 7th, American researchers found through in-depth analysis of federal health data that people with new coronary pneumonia were infected after infection.
Observations of the long-term effects of COVID-19 have found that COVID-19 can lead to serious cardiovascular complications and death, said senior author Ziad Al-Aly, an assistant professor of medicine at the University of Washington
Al-Avery also said that for those who were clearly at risk for heart disease before contracting the disease, COVID-19 may amplify that risk
The Covid-19 patients in the study were mostly older white men, and the researchers also analyzed data that included women and adults of all ages and races
"Some people may think 4% is a small number, but considering the severity of the epidemic, it is not
Compared with a control group without any infection, people with COVID-19 were 72% more likely to develop coronary heart disease, 63% more likely to have a heart attack, and 52% more likely to have a stroke
Overall, people with COVID-19 were 55% more likely than others to experience major adverse cardiovascular events, including heart attack, stroke and death
